DHX37 and pancreatic ductal adenocarcinoma: Besides, in bladder carcinoma, cervical squamous cell carcinoma, esophageal squamous cell carcinoma, ovarian cancer, kidney renal papillary cell carcinoma, pancreatic ductal adenocarcinoma, pheochromocytoma, paraganglioma, and thymoma, DHX37 had no association with prognosis.